We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
-6.11%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$2.26B
AUM Growth
-$574M
Cap. Flow
-$292M
Cap. Flow %
-12.92%
Top 10 Hldgs %
18.68%
Holding
241
New
25
Increased
36
Reduced
128
Closed
33

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$19.9M
2
MTDR icon
Matador Resources
MTDR
+$17M
3
PCRX icon
Pacira BioSciences
PCRX
+$16.9M
4
CRS icon
Carpenter Technology
CRS
+$13.2M
5
HAE icon
Haemonetics
HAE
+$12.1M

Sector Composition

Rank Sector Weight
1 Technology 20.57%
2 Financials 18.45%
3 Healthcare 18.05%
4 Industrials 15.09%
5 Consumer Discretionary 14.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOOR
226
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-132,048
Closed -$15.6M
PAYA
227
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
-240,781
Closed -$1.53M
ZNGA
228
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-19,650
Closed -$126K
ARNA
229
DELISTED
Arena Pharmaceuticals Inc
ARNA
-76,993
Closed -$7.16M

Similar funds

Emerald Mutual Fund Advisers Trust's Q1 2022 Portfolio in Review

As of Q1 2022, Emerald Mutual Fund Advisers Trust held 241 positions worth $2.26B, down 20% from $2.84B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Mutual Fund Advisers Trust withdrew a net $292M in Q1 2022, closing 33 positions and reducing 128 holdings. Its most notable exit was Blueprint Medicines, an estimated $23.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Emerald Mutual Fund Advisers Trust opened a new position in Shift4 worth $23.4M.

  • Emerald Mutual Fund Advisers Trust's largest Q1 2022 buy was Shift4: 377,109 shares worth $23.4M.
  • Emerald Mutual Fund Advisers Trust added most to ANI Pharmaceuticals in Q1 2022, an estimated $7.83M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q1 2022 reduction was Eastern Bankshares, cutting an estimated $25.4M.
  • Emerald Mutual Fund Advisers Trust fully exited Blueprint Medicines in Q1 2022, selling an estimated $23.8M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 19% of its $2.26B portfolio in Q1 2022.
  • Emerald Mutual Fund Advisers Trust opened 25 new positions and closed 33 in Q1 2022.
  • Emerald Mutual Fund Advisers Trust's portfolio value fell 20% quarter-over-quarter to $2.26B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2022, filed 29 Apr 2022.